BeyondSpring Inc. Depreciation
BeyondSpring Inc. (BYSI) reported Depreciation of $38.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-14
- BeyondSpring Inc. depreciation for the quarter ending 2026-06-30 was $19.00K, a 76.83% decline year-over-year.
- BeyondSpring Inc. depreciation for the quarter ending 2026-03-31 was $19.00K, a 76.25% decline year-over-year.
- BeyondSpring Inc. depreciation for the quarter ending 2025-12-31 was -$156.00K, a 880.00% decline year-over-year.
- BeyondSpring Inc. depreciation for the quarter ending 2025-09-30 was $81.00K, a 2.41% decline year-over-year.
- BeyondSpring Inc. depreciation for fiscal 2025 was $87.00K, a 69.47% decline from fiscal 2024.
- BeyondSpring Inc. depreciation for fiscal 2024 was $285.00K, a 5.63% decline from fiscal 2023.
- BeyondSpring Inc. depreciation for fiscal 2023 was $302.00K.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $38.00K 10-Q · filed 2026-08-14 | -$118.00K derived: sum of 3 quarters · filed 2026-08-14 | -$37.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $19.00K 10-Q · filed 2026-05-13 | -$137.00K derived: sum of 2 quarters · filed 2026-05-13 | -$56.00K derived: sum of 3 quarters · filed 2026-05-13 | $26.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$156.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$75.00K derived: sum of 2 quarters · filed 2026-03-25 | $7.00K derived: sum of 3 quarters · filed 2026-08-14 | $87.00K 10-K · filed 2026-03-25 |
| 2025-09-30 | $81.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $163.00K derived: sum of 2 quarters · filed 2026-08-14 | $243.00K 10-Q · filed 2025-11-12 | $263.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $82.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $162.00K 10-Q · filed 2026-08-14 | $182.00K derived: sum of 3 quarters · filed 2026-08-14 | $265.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $80.00K 10-Q · filed 2026-05-13 | $100.00K derived: sum of 2 quarters · filed 2026-05-13 | $183.00K derived: sum of 3 quarters · filed 2026-05-13 | $298.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $103.00K derived: sum of 2 quarters · filed 2026-03-25 | $218.00K derived: sum of 3 quarters · filed 2026-03-25 | $285.00K 10-K · filed 2026-03-25 |
| 2024-09-30 | $83.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $198.00K derived: sum of 2 quarters · filed 2025-11-12 | $265.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $115.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $182.00K 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | $67.00K 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | $302.00K 10-K · filed 2025-03-27 | |||
| 2022-12-31 | $232.00K 20-F · filed 2023-04-18 | |||
| 2021-12-31 | $7.00K derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | $24.00K derived: sum of 2 quarters · filed 2023-04-18 | $44.00K derived: sum of 3 quarters · filed 2023-04-18 | $61.00K 20-F · filed 2023-04-18 |
| 2021-09-30 | $17.00K 6-K · filed 2021-12-30 | $37.00K derived: sum of 2 quarters · filed 2021-12-30 | $54.00K 6-K · filed 2021-12-30 | $77.00K derived: sum of 4 quarters · filed 2023-04-18 |
| 2021-06-30 | $20.00K 6-K · filed 2021-09-10 | $37.00K 6-K · filed 2021-09-10 | $60.00K derived: sum of 3 quarters · filed 2023-04-18 | $82.00K derived: sum of 4 quarters · filed 2023-04-18 |
| 2021-03-31 | $17.00K 6-K · filed 2021-06-16 | $40.00K derived: sum of 2 quarters · filed 2023-04-18 | $62.00K derived: sum of 3 quarters · filed 2023-04-18 | $79.00K derived: sum of 4 quarters · filed 2023-04-18 |
| 2020-12-31 | $23.00K derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | $45.00K derived: sum of 2 quarters · filed 2023-04-18 | $62.00K derived: sum of 3 quarters · filed 2023-04-18 | $77.00K 20-F · filed 2023-04-18 |
| 2020-09-30 | $22.00K 6-K · filed 2021-12-30 | $39.00K derived: sum of 2 quarters · filed 2021-12-30 | $54.00K 6-K · filed 2021-12-30 | $70.00K derived: sum of 4 quarters · filed 2022-04-14 |
| 2020-06-30 | $17.00K 6-K · filed 2021-09-10 | $32.00K 6-K · filed 2021-09-10 | $48.00K derived: sum of 3 quarters · filed 2022-04-14 | $69.00K derived: sum of 4 quarters · filed 2022-04-14 |
| 2020-03-31 | $15.00K 6-K · filed 2021-06-16 | $31.00K derived: sum of 2 quarters · filed 2022-04-14 | $52.00K derived: sum of 3 quarters · filed 2022-04-14 | $75.00K derived: sum of 4 quarters · filed 2022-04-14 |
| 2019-12-31 | $16.00K derived: 20-F 12 month − 6-K 9 month · filed 2022-04-14 | $37.00K derived: sum of 2 quarters · filed 2022-04-14 | $60.00K derived: sum of 3 quarters · filed 2022-04-14 | $77.00K 20-F · filed 2022-04-14 |
| 2019-09-30 | $21.00K 6-K · filed 2020-11-17 | $44.00K derived: sum of 2 quarters · filed 2020-11-17 | $61.00K 6-K · filed 2020-11-17 | $86.00K derived: sum of 4 quarters · filed 2021-04-30 |
| 2019-06-30 | $23.00K 6-K · filed 2020-09-03 | $41.00K 6-K · filed 2020-09-03 | $65.00K derived: sum of 3 quarters · filed 2021-04-30 | $74.00K derived: sum of 4 quarters · filed 2021-04-30 |
| 2019-03-31 | $23.00K 6-K · filed 2020-06-11 | $42.00K derived: sum of 2 quarters · filed 2021-04-30 | $51.00K derived: sum of 3 quarters · filed 2021-04-30 | $59.00K derived: sum of 4 quarters · filed 2021-04-30 |
| 2018-12-31 | $19.00K derived: 20-F 12 month − 6-K 9 month · filed 2021-04-30 | $28.00K derived: sum of 2 quarters · filed 2021-04-30 | $36.00K derived: sum of 3 quarters · filed 2021-04-30 | $48.00K 20-F · filed 2021-04-30 |
| 2018-09-30 | $9.00K 6-K · filed 2019-12-18 | $17.00K derived: sum of 2 quarters · filed 2019-12-18 | $29.00K 6-K · filed 2019-12-18 | $39.00K derived: sum of 4 quarters · filed 2020-04-30 |
| 2018-06-30 | $8.00K 6-K · filed 2019-09-18 | $20.00K 6-K · filed 2019-09-18 | $30.00K derived: sum of 3 quarters · filed 2020-04-30 | $39.00K derived: sum of 4 quarters · filed 2020-04-30 |
| 2018-03-31 | $12.00K 6-K · filed 2019-07-10 | $22.00K derived: sum of 2 quarters · filed 2020-04-30 | $31.00K derived: sum of 3 quarters · filed 2020-04-30 | $38.00K derived: sum of 4 quarters · filed 2020-04-30 |
| 2017-12-31 | $10.00K derived: 20-F 12 month − 6-K 9 month · filed 2020-04-30 | $19.00K derived: sum of 2 quarters · filed 2020-04-30 | $26.00K derived: sum of 3 quarters · filed 2020-04-30 | $32.00K 20-F · filed 2020-04-30 |
| 2017-09-30 | $9.00K 6-K · filed 2017-11-09 | $16.00K derived: sum of 2 quarters · filed 2018-10-23 | $22.00K 6-K · filed 2017-11-09 | $26.00K derived: sum of 4 quarters · filed 2019-04-30 |
| 2017-06-30 | $7.00K 6-K · filed 2018-10-23 | $13.00K 6-K · filed 2018-10-23 | $17.00K derived: sum of 3 quarters · filed 2019-04-30 | $23.00K derived: sum of 4 quarters · filed 2019-04-30 |
| 2017-03-31 | $6.00K 6-K · filed 2018-06-21 | $10.00K derived: sum of 2 quarters · filed 2019-04-30 | $16.00K derived: sum of 3 quarters · filed 2019-04-30 | $20.00K derived: sum of 4 quarters · filed 2019-04-30 |
| 2016-12-31 | $4.00K derived: 20-F 12 month − 6-K 9 month · filed 2019-04-30 | $10.00K derived: sum of 2 quarters · filed 2019-04-30 | $14.00K derived: sum of 3 quarters · filed 2019-04-30 | $18.00K 20-F · filed 2019-04-30 |
| 2016-09-30 | $6.00K 6-K · filed 2017-11-09 | $10.00K derived: sum of 2 quarters · filed 2017-11-09 | $14.00K 6-K · filed 2017-11-09 | |
| 2016-06-30 | $4.00K derived: 6-K 6 month − 6-K 3 month · filed 2017-08-21 | $9.00K 6-K · filed 2017-08-21 | ||
| 2016-03-31 | $5.00K 6-K · filed 2017-05-22 | |||
| 2015-12-31 | $10.00K 20-F · filed 2018-04-03 | |||
| 2014-12-31 | $0.00 20-F · filed 2017-04-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |